TABLE A1.

Efficacy variables (PP set)a

VariableValue
CadazolidVancomycin (125 mg QID)
250 mg BID500 mg BID1,000 mg BID
Clinical cure rate [n (%)]13 (81.3)15 (78.9)12 (70.6)13 (68.4)
    80% CI62.9, 92.962.2, 90.552.2, 84.951.1, 82.5
    n16191719
Modified clinical cure rate [n (%)]16 (100.0)18 (94.7)16 (94.1)17 (89.5)
    80% CI86.6, 100.081.0, 99.479.0, 99.474.3, 97.2
    n16191719
  • a The PP analysis set included all subjects included in the mITT analysis set without major protocol deviations or conditions that might affect the evaluation of the effect of the study drug on the primary endpoint.